{"canonical":"https://abierto.us/vendors/eisana-corp-luw6w9wl7cx5","key":"LUW6W9WL7CX5","name":"EISANA CORP","uei":"LUW6W9WL7CX5","city":"SPRING","state":"TX","awards":1,"obligated":"0","notices_won":0,"top_agency_name":"National Institutes of Health","top_naics":"541715","cage":"8HM61","parent_name":"EISANA CORP","also_known_as":[],"country":"USA","actions":2,"first_action":"2024-05-02","last_action":"2024-07-24","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"0.00"}],"places":[{"key":"TX","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"7529","name":"National Institutes of Health","awards":1,"obligated":"0.00"}],"set_asides":[{"key":"SMALL BUSINESS SET ASIDE - TOTAL","name":null,"awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"0.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","name":null,"awards":1,"obligated":"0.00"}],"product_service_codes":[{"key":"AN12","name":null,"awards":1,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_AWD_75N91023C00036_7529_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75N91023C00036_7529_-NONE-_-NONE-/","piid":"75N91023C00036","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"LUW6W9WL7CX5","recipient_name":"EISANA CORP","recipient_uei":"LUW6W9WL7CX5","recipient_cage":"8HM61","recipient_city":"SPRING","recipient_state":"TX","sub_name":"National Institutes of Health","office_name":"NIH NCI","office_key":"o-75N910","first_action_date":"2024-05-02","last_action_date":"2024-07-24","actions":2,"obligated":"0","current_total_value":"399824.00","potential_total_value":"454824.00","naics":"541715","psc":"AN12","extent_competed":"FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES","set_aside":"SMALL BUSINESS SET ASIDE - TOTAL","offers_received":2,"description":"TOPIC 447: DEVELOPMENT AND TESTING OF A NON-INVASIVE CRYO-DEVICE TO PREVENT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN HANDS AND FEET OF CANCER PATIENTS RECEIVING TAXOL FOR BREAST CANCER.","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}